Abstract

Huron Consulting will report second-quarter 2026 results on July 28, 2026 Post-Mkt; this preview summarizes consensus revenue, margin, and EPS expectations, reviews last quarter’s delivery, and examines the outlook for its Healthcare, Education, and Commercial segments alongside the balance of institutional opinions.

Market Forecast

Consensus for the current quarter points to revenue of US dollars 448.97 million, EBIT of US dollars 58.58 million, and adjusted EPS of 2.17, implying year-over-year growth of 11.50% for revenue, 9.03% for EBIT, and 21.18% for EPS. Based on the company’s last report, investors expect a stable gross profit margin profile near the low-30s and a low-to-mid single-digit net profit margin alongside a double-digit EPS expansion year over year. The main business highlights remain concentrated in Healthcare, Education, and Commercial advisory, with Healthcare continuing to be the largest revenue contributor and the primary source of project pipeline visibility. The most promising segment appears to be Healthcare, at US dollars 229.19 million last quarter, given its larger scale and resilient demand, though Education is positioned for incremental growth from ongoing digital and transformation programs.

Last Quarter Review

Huron Consulting last reported revenue of US dollars 443.71 million, a gross profit margin of 30.54%, GAAP net profit attributable to the parent company of US dollars 23.25 million, a net profit margin of 5.24%, and adjusted EPS of 1.73, up 2.98% year over year. A key financial highlight was better-than-expected execution with EBIT of US dollars 45.51 million, exceeding consensus and reflecting operating leverage on a larger services base. By segment, last quarter’s revenue mix was Healthcare at US dollars 229.19 million, Education at US dollars 129.61 million, and Commercial at US dollars 92.97 million, underscoring Healthcare’s leading contribution and the growing scale in Education; year-over-year growth by segment was not disclosed.

Current Quarter Outlook

Main business trajectory

The core consulting franchise is centered on project-based transformation and managed services across Healthcare, Education, and Commercial clients, supported by technology enablement and data/analytics capabilities. With consensus revenue expected at US dollars 448.97 million, the implied trajectory points to continued double-digit year-over-year expansion driven by backlog conversion and steady demand for performance improvement, revenue cycle, and digital modernization mandates. Gross margin is expected to remain around the low-30% level, consistent with the prior quarter, which signals pricing discipline and utilization stability despite staffing cost inflation. The net margin framework in the low-to-mid single digits aligns with historical cadence in a labor-intensive model, while the forecast EPS of 2.17 suggests healthier operating leverage than the headline net margin might imply, given disciplined SG&A and a favorable mix of higher-value engagements.

Most promising business

Healthcare remains the most promising segment, with last quarter revenue of US dollars 229.19 million and continued institutional focus on hospital and health system performance improvement, revenue cycle optimization, and care delivery redesign. The pipeline in Healthcare is supported by ongoing reimbursement complexity, payer mix shifts, and provider consolidation that create durable consulting needs, which can extend into managed services arrangements with recurring characteristics. Given the scale advantage of Healthcare within the portfolio, small improvements in pricing, utilization, or engagement length can have an outsized earnings contribution this quarter. Education is poised for incremental gains as universities and research institutions prioritize operational efficiency and digital transformation, but it remains smaller in absolute dollars than Healthcare; Commercial provides optionality through sector-diversified strategy and operations work.

Key stock-price drivers this quarter

Earnings sensitivity will hinge on utilization rates, pricing on new awards, and the mix of project-based versus managed services work. A higher share of longer-duration, technology-enabled engagements could hold gross margin near the low-30% area and reinforce EPS momentum around the 2.17 forecast. Revenue visibility into the back half is another pivotal factor; commentary on backlog and book-to-bill will shape expectations for sequential revenue trends and help investors assess whether the recent double-digit growth can continue. Any discussion of hiring pace, attrition, and labor cost management will inform the operating margin path; better-than-expected leverage in delivery teams would strengthen confidence in sustained EPS growth. Finally, segment color on Healthcare project starts and the flow of Education digital programs will influence investor views on mix quality and durability.

Analyst Opinions

Analyst commentary gathered in the year-to-date window indicates a majority positive stance on Huron Consulting’s near-term setup, with bullish views outweighing cautious ones. The supportive camp emphasizes the double-digit revenue growth outlook for the quarter, stability in gross margins around low-30%, and the upside risk to EPS from favorable engagement mix and disciplined operating expense control. Analysts also point to the Healthcare segment’s larger scale and durable demand drivers as a foundation for sustained backlog conversion, while Education’s modernization and technology workstreams provide incremental growth.

Within the majority view, several institutions highlight that last quarter’s EBIT outperformance versus estimates provides a constructive read-through to execution this quarter. The argument is that the combination of healthy project pipelines, price discipline, and measured hiring can preserve utilization and offset wage inflation pressure. Forecast EPS of 2.17, up 21.18% year over year, is frequently cited as the key data point supporting the positive stance, with incremental upside possible if higher-margin technology-enabled work comprises a larger share of delivery.

On balance, these analysts expect the company to meet or modestly exceed consensus revenue near US dollars 448.97 million, keep gross margin in the low-30% range, and deliver EPS at or above the 2.17 forecast. They also stress that color on backlog, mix, and hiring will be decisive for the second-half trajectory, but that the preconditions for continued growth currently appear favorable given the scale and momentum in Healthcare and the steady contributions from Education and Commercial.